Nitrofurantoin + Camylofin DihydrochlorideThird Party Manufacturing in India

Nitrofurantoin + Camylofin Dihydrochloride works by combining a urinary tract-specific antibiotic with a smooth muscle relaxant.

Nitrofurantoin is reduced by bacterial enzymes into reactive intermediates that damage bacterial DNA, RNA, and proteins, exerting a strong bactericidal effect within the urinary tract. Camylofin acts directly on smooth muscles and possesses weak anticholinergic properties, reducing spasms in the genitourinary tract. This synergistic biological effect helps the body eradicate urinary infections while simultaneously alleviating the associated painful spasms.

Unlike standard antibiotic therapies, Nitrofurantoin + Camylofin Dihydrochloride addresses both the infectious cause and the painful symptoms. It is highly effective for patients suffering from urinary tract infections accompanied by severe dysuria.

Therapeutic Uses

Nitrofurantoin + Camylofin Dihydrochloride is prescribed for the treatment of:

• Urinary Tract Infections (UTIs): Effectively eradicates susceptible bacterial pathogens in the bladder and urinary tract.
• Bladder Spasms: Relieves the painful urgency, frequency, and suprapubic pain associated with UTIs.
• Dysuria: Alleviates burning sensations and discomfort during urination caused by infection and inflammation.

Why Manufacturers Choose Nitrofurantoin + Camylofin Dihydrochloride

This combination offers a significant clinical advantage by providing both antimicrobial action and symptomatic relief in a single dosage form. The rising prevalence of complicated UTIs and the need for better patient compliance drive its strong market presence.

This makes Nitrofurantoin + Camylofin Dihydrochloride one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.